
Gigi Georgiana Huang
Examiner (ID: 12753)
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621 |
| Total Applications | 781 |
| Issued Applications | 217 |
| Pending Applications | 66 |
| Abandoned Applications | 506 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8253194
[patent_doc_number] => 20120157521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'TREATMENT OF MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/392435
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8686
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157521.pdf
[firstpage_image] =>[orig_patent_app_number] => 13392435
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392435 | TREATMENT OF MACULAR DEGENERATION | Aug 26, 2010 | Abandoned |
Array
(
[id] => 6342720
[patent_doc_number] => 20100329991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Medicinal preparation particularly for the treatment of slipped discs hernias'
[patent_app_type] => utility
[patent_app_number] => 12/870258
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1912
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0329/20100329991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870258 | Medicinal preparation particularly for the treatment of slipped discs hernias | Aug 26, 2010 | Issued |
Array
(
[id] => 6630414
[patent_doc_number] => 20100311716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA'
[patent_app_type] => utility
[patent_app_number] => 12/858739
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4836
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12858739
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/858739 | USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA | Aug 17, 2010 | Abandoned |
Array
(
[id] => 6562977
[patent_doc_number] => 20100272791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'COMPOSITION HAVING EFFECT ON TREATMENT AND PREVENTION OF DRY EYE SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/832395
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272791.pdf
[firstpage_image] =>[orig_patent_app_number] => 12832395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/832395 | COMPOSITION HAVING EFFECT ON TREATMENT AND PREVENTION OF DRY EYE SYNDROME | Jul 7, 2010 | Abandoned |
Array
(
[id] => 6448667
[patent_doc_number] => 20100280089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'USE OF INHIBITORS OF JUN N-TERMINAL KINASES FOR THE TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/831702
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4171
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12831702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831702 | USE OF INHIBITORS OF JUN N-TERMINAL KINASES FOR THE TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OCULAR DISEASES | Jul 6, 2010 | Abandoned |
Array
(
[id] => 15099467
[patent_doc_number] => 10471027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Pharmacology of visual cycle modulators
[patent_app_type] => utility
[patent_app_number] => 12/830155
[patent_app_country] => US
[patent_app_date] => 2010-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14241
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12830155
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/830155 | Pharmacology of visual cycle modulators | Jul 1, 2010 | Issued |
Array
(
[id] => 6026568
[patent_doc_number] => 20110054029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'WATER-SOLUBLE DIETARY FATTY ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/823945
[patent_app_country] => US
[patent_app_date] => 2010-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8349
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12823945
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/823945 | WATER-SOLUBLE DIETARY FATTY ACIDS | Jun 24, 2010 | Abandoned |
Array
(
[id] => 8269948
[patent_doc_number] => 08211450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-03
[patent_title] => 'Ophthalmic composition'
[patent_app_type] => utility
[patent_app_number] => 12/774419
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9038
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12774419
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/774419 | Ophthalmic composition | May 4, 2010 | Issued |
Array
(
[id] => 6616977
[patent_doc_number] => 20100310642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Topical Drug Delivery Systems for Ophthalmic Use'
[patent_app_type] => utility
[patent_app_number] => 12/774600
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16385
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12774600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/774600 | Topical drug delivery systems for ophthalmic use | May 4, 2010 | Issued |
Array
(
[id] => 8043445
[patent_doc_number] => 20120071448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'S1P3 Receptor Inhibitors for Treating Conditions of the Eye'
[patent_app_type] => utility
[patent_app_number] => 13/318583
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17018
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071448.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318583
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318583 | S1P3 Receptor Inhibitors for Treating Conditions of the Eye | May 3, 2010 | Abandoned |
Array
(
[id] => 8184108
[patent_doc_number] => 20120114637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/265530
[patent_app_country] => US
[patent_app_date] => 2010-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 107627
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114637.pdf
[firstpage_image] =>[orig_patent_app_number] => 13265530
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265530 | MTOR PATHWAY INHIBITORS FOR TREATING OCULAR DISORDERS | May 3, 2010 | Abandoned |
Array
(
[id] => 8173949
[patent_doc_number] => 20120108665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/318770
[patent_app_country] => US
[patent_app_date] => 2010-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10656
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20120108665.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318770 | METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS | May 2, 2010 | Abandoned |
Array
(
[id] => 6578225
[patent_doc_number] => 20100273892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/768554
[patent_app_country] => US
[patent_app_date] => 2010-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21444
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273892.pdf
[firstpage_image] =>[orig_patent_app_number] => 12768554
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/768554 | FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES | Apr 26, 2010 | Abandoned |
Array
(
[id] => 8591428
[patent_doc_number] => 08349303
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-01-08
[patent_title] => 'Polymeric quaternium compounds'
[patent_app_type] => utility
[patent_app_number] => 12/758860
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9812
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12758860
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758860 | Polymeric quaternium compounds | Apr 12, 2010 | Issued |
Array
(
[id] => 8141341
[patent_doc_number] => 20120095215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF EYE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/262531
[patent_app_country] => US
[patent_app_date] => 2010-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28587
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20120095215.pdf
[firstpage_image] =>[orig_patent_app_number] => 13262531
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/262531 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF EYE DISEASES | Mar 29, 2010 | Abandoned |
Array
(
[id] => 6395218
[patent_doc_number] => 20100178265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'HAIR CONDITIONING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/728551
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20100178265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728551
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728551 | HAIR CONDITIONING COMPOSITION | Mar 21, 2010 | Abandoned |
Array
(
[id] => 7670194
[patent_doc_number] => 20110319463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'PREVENTIVE OR THERAPEUTIC AGENTS FOR OPTIC NERVE DISORDERS COMPRISING 4,6-DICHLORO-1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AS ACTIVE INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/255563
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6671
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255563
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/255563 | PREVENTIVE OR THERAPEUTIC AGENTS FOR OPTIC NERVE DISORDERS COMPRISING 4,6-DICHLORO-1H-INDOLE-2-CARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AS ACTIVE INGREDIENTS | Mar 9, 2010 | Abandoned |
Array
(
[id] => 6636638
[patent_doc_number] => 20100226981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A GABAPENTIN PRODRUG'
[patent_app_type] => utility
[patent_app_number] => 12/718857
[patent_app_country] => US
[patent_app_date] => 2010-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16295
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20100226981.pdf
[firstpage_image] =>[orig_patent_app_number] => 12718857
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/718857 | ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A GABAPENTIN PRODRUG | Mar 4, 2010 | Abandoned |
Array
(
[id] => 10888240
[patent_doc_number] => 08912236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-16
[patent_title] => 'Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye'
[patent_app_type] => utility
[patent_app_number] => 12/716624
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3907
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12716624
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716624 | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye | Mar 2, 2010 | Issued |
Array
(
[id] => 8056207
[patent_doc_number] => 20120077836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/202590
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25166
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077836.pdf
[firstpage_image] =>[orig_patent_app_number] => 13202590
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202590 | METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF | Feb 25, 2010 | Abandoned |